LIMINATUS PHARM Revenue 1971-1970 | LIMN

LIMINATUS PHARM revenue from 1971 to 1970. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
LIMINATUS PHARM Annual Revenue
(Millions of US $)
LIMINATUS PHARM Quarterly Revenue
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.886B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Aduro Clean Technologies (ADUR) Canada $0.157B 0.00
Range Capital Acquisition (RANG) United States $0.144B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.099B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.092B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.040B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.035B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
SMART DGTL GRP (SDM) $0.000B 0.00
WINCHESTER BCP (WSBK) $0.000B 0.00
YUANBAO INC (YB) China $0.000B 0.00
CANTOR EQ PT II (CEPT) $0.000B 0.00